loading
Schlusskurs vom Vortag:
$22.17
Offen:
$22.23
24-Stunden-Volumen:
469.36K
Relative Volume:
0.69
Marktkapitalisierung:
$1.04B
Einnahmen:
$681.75M
Nettoeinkommen (Verlust:
$70.47M
KGV:
15.47
EPS:
1.45
Netto-Cashflow:
$173.19M
1W Leistung:
-1.32%
1M Leistung:
-7.43%
6M Leistung:
-0.09%
1J Leistung:
+10.98%
1-Tages-Spanne:
Value
$22.15
$22.95
1-Wochen-Bereich:
Value
$21.44
$23.14
52-Wochen-Spanne:
Value
$11.16
$27.98

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
Firmenname
Pacira Biosciences Inc
Name
Telefon
650-242-8052
Name
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
Mitarbeiter
790
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
PCRX's Discussions on Twitter

Vergleichen Sie PCRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
22.43 1.05B 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-30 Hochstufung Truist Sell → Hold
2024-08-13 Herabstufung Truist Buy → Sell
2024-08-12 Herabstufung JP Morgan Overweight → Underweight
2024-08-12 Herabstufung Piper Sandler Overweight → Neutral
2024-08-12 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-08-12 Herabstufung Raymond James Outperform → Mkt Perform
2024-07-03 Herabstufung Barclays Overweight → Equal Weight
2024-03-07 Fortgesetzt JP Morgan Overweight
2023-12-20 Eingeleitet Raymond James Outperform
2023-08-03 Hochstufung TD Cowen Market Perform → Outperform
2023-01-31 Fortgesetzt Wedbush Outperform
2022-10-21 Fortgesetzt Jefferies Buy
2022-01-03 Fortgesetzt JP Morgan Overweight
2021-07-26 Hochstufung JP Morgan Neutral → Overweight
2021-04-21 Fortgesetzt JP Morgan Neutral
2021-04-09 Eingeleitet Berenberg Buy
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2021-02-11 Herabstufung Northland Capital Outperform → Market Perform
2021-01-21 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-09-21 Hochstufung Northland Capital Market Perform → Outperform
2020-07-06 Bestätigt Needham Buy
2020-05-27 Eingeleitet Guggenheim Neutral
2020-04-07 Eingeleitet Northland Capital Outperform
2020-03-20 Hochstufung SVB Leerink Mkt Perform → Outperform
2020-02-24 Bestätigt H.C. Wainwright Buy
2020-01-24 Eingeleitet SunTrust Buy
2020-01-23 Eingeleitet SunTrust Buy
2019-11-06 Eingeleitet BTIG Research Buy
2019-06-11 Eingeleitet Barclays Overweight
2019-05-06 Hochstufung Mizuho Underperform → Neutral
2019-05-02 Hochstufung Stifel Sell → Hold
2019-02-01 Herabstufung Mizuho Neutral → Underperform
2018-08-06 Herabstufung BofA/Merrill Buy → Neutral
2018-04-09 Bestätigt H.C. Wainwright Buy
2018-03-21 Bestätigt Mizuho Neutral
2018-02-16 Herabstufung Needham Buy → Hold
2018-01-19 Eingeleitet Seaport Global Securities Buy
2018-01-04 Bestätigt Canaccord Genuity Buy
2018-01-03 Eingeleitet Leerink Partners Mkt Perform
Alle ansehen

Pacira Biosciences Inc Aktie (PCRX) Neueste Nachrichten

pulisher
Jul 22, 2025

Pacira BioSciences Inc. Stock Analysis and ForecastMarket-crushing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Pacira, JNJ in pact to boost Zilretta availability (PCRX) - Seeking Alpha

Jul 22, 2025
pulisher
Jul 22, 2025

Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Major Expansion: J&J to Co-Promote Pacira's ZILRETTA Across 7M Annual Knee Injections Market - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Pacira BioSciences Inc. stock priceRapid profit acceleration - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bank of New York Mellon Corp Decreases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Pacira BioSciences Inc. stockFree Stock Market Return Analysis - Autocar Professional

Jul 22, 2025
pulisher
Jul 21, 2025

Is Pacira BioSciences Inc. a good long term investmentGame-changing capital returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Zacks Research Has Negative Estimate for PCRX Q4 Earnings - Defense World

Jul 21, 2025
pulisher
Jul 19, 2025

Teacher Retirement System of Texas Lowers Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Further Weakness as Pacira BioSciences (NASDAQ:PCRX) Drops 5.9% This Week, Taking Three-year Losses to 60% - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Shareholders in Pacira BioSciences (NASDAQ:PCRX) have lost 60%, as stock drops 5.9% this past week - simplywall.st

Jul 18, 2025
pulisher
Jul 17, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRA) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 16, 2025

Why Pacira BioSciences Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Pacira BioSciences Investors: Know Your Rights Amid Lawsuit - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit - PR Newswire

Jul 16, 2025
pulisher
Jul 16, 2025

Principal Financial Group Inc. Increases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Brokerages Set Pacira BioSciences, Inc. (NASDAQ:PCRX) Target Price at $26.44 - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Pacira BioSciences announces workforce reduction and facility changes By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Pacira BioSciences Inc. stock price move sharplyFree Real-Time Stock Data - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Pacira announces layoffs due to efficiencies in Exparel production - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Pacira BioSciences Gene Therapy Shows Sustained Knee Osteoarthritis Improvement - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Allspring Global Investments Holdings LLC Makes New $277,000 Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Pacira BioSciences (PCRX) Plunges 3.33% Amid Restructuring - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRA) And Encourages Investors to Connect - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Pacira BioSciences announces workforce reduction and facility changes - Investing.com Australia

Jul 10, 2025
pulisher
Jul 10, 2025

Pacira stock slips amid layoffs in U.S. (PCRX:NASDAQ) - Seeking Alpha

Jul 10, 2025
pulisher
Jul 10, 2025

Pacira BioSciences announces workforce reduction - MarketScreener

Jul 10, 2025
pulisher
Jul 08, 2025

GAMMA Investing LLC Increases Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jul 08, 2025
pulisher
Jul 08, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jul 08, 2025
pulisher
Jul 08, 2025

Pacira Pharmaceuticals Secures New $300M Credit Facility - The Globe and Mail

Jul 08, 2025
pulisher
Jul 07, 2025

Murano (MRNO) targets $500M for Bitcoin Treasury via new SEPA | PCRX SEC FilingForm 8-K - Stock Titan

Jul 07, 2025
pulisher
Jul 07, 2025

Where are the Opportunities in (PCRX) - news.stocktradersdaily.com

Jul 07, 2025
pulisher
Jul 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 04, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jul 04, 2025
pulisher
Jul 03, 2025

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

Pacira Issues Major Stock Compensation Package: 15,800 Shares Granted to New Executives - Stock Titan

Jul 03, 2025
pulisher
Jul 03, 2025

Pacira BioSciences: Equity Incentives Fueling Long-Term Growth in Non-Opioid Pain Management - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

PCRX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Pacira BioSciences, Inc. - ACCESS Newswire

Jul 02, 2025
pulisher
Jun 29, 2025

State of Alaska Department of Revenue Has $635,000 Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 29, 2025
pulisher
Jun 23, 2025

Upper Peninsula ABC 10News, Sports, Weather and More from Michigan's Upper Peninsula - FinancialContent

Jun 23, 2025
pulisher
Jun 20, 2025

Financial Contrast: Pacira BioSciences (NASDAQ:PCRX) & Antibe Therapeutics (OTCMKTS:ATBPD) - Defense World

Jun 20, 2025

Finanzdaten der Pacira Biosciences Inc-Aktie (PCRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.34
price up icon 1.09%
$14.93
price up icon 1.70%
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
$132.75
price up icon 0.70%
$297.89
price up icon 1.63%
Kapitalisierung:     |  Volumen (24h):